I

Idera Pharmaceuticals Inc
F:HXXB

Watchlist Manager
Idera Pharmaceuticals Inc
F:HXXB
Watchlist
Price: 2.8 EUR Market Closed
Market Cap: 174.4m EUR

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of HXXB.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HXXB Intrinsic Value
Not Available
I
Base Case Scenario

Fundamental Analysis

Idera Pharmaceuticals Inc
F:HXXB
US
Biotechnology
Market Cap
174.4m EUR
IPO
Jan 25, 1996
US
Biotechnology
Market Cap
174.4m EUR
IPO
Jan 25, 1996
Price
€false
EPS
$false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Idera Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Idera Pharmaceuticals Inc

Balance Sheet Decomposition
Idera Pharmaceuticals Inc

Current Assets 17.9m
Cash & Short-Term Investments 12m
Receivables 4.2m
Other Current Assets 1.6m
Non-Current Assets 83.2m
PP&E 544k
Intangibles 82.7m
Efficiency

Free Cash Flow Analysis
Idera Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Idera Pharmaceuticals Inc

Revenue
4.9m USD
Operating Expenses
-24.4m USD
Operating Income
-19.5m USD
Other Expenses
-3.8m USD
Net Income
-23.4m USD
Fundamental Scores

HXXB Profitability Score
Profitability Due Diligence

Idera Pharmaceuticals Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

23/100
Profitability
Score

Idera Pharmaceuticals Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

HXXB Solvency Score
Solvency Due Diligence

Idera Pharmaceuticals Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
43/100
Solvency
Score

Idera Pharmaceuticals Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HXXB Price Targets Summary
Idera Pharmaceuticals Inc

There are no price targets for HXXB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for HXXB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest